Canopy Growth (TSX:WEED) Tanks Again: How Low Could the Stock Go?

Canopy Growth just reported weak quarterly results. What’s next for this cannabis stock?

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

Canopy Growth (TSX:WEED)(NASDAQ:CGC) is down 17% for the day at the time of writing, hitting a new multi-year low under $6 per share. Investors who stayed on the sidelines during the rout over the past 15 months are wondering if Canopy Growth stock is finally oversold and undervalued.

Canopy Growth results

Canopy Growth reported weak results for its latest quarter. The business saw net revenue drop 25% to $111.8 million from $148.4 million in the same period last year. The big hit came as global cannabis sales plunged from $101.3 million to just $66 million. Canopy Growth’s other consumer products sales, including the drinks business, generated more stable results with revenue coming in at $45.8 million compared to $47.1 million in the same three months last year.

Canopy Growth reported a net loss of $575 million, or $1.46 per share, for the latest quarter. The net loss in the same period in the previous year was worse at $700 million.

Management is still optimistic on the business with a goal of reaching profitability in 2024. The company is trimming costs and focusing on key strategic markets. Canopy Growth cut 250 jobs in a recent downsizing and has reduced its retail footprint by closing stores and exiting some international markets.

Opportunities

The entire cannabis industry is hoping the U.S. will eventually legalize the sale of cannabis products at the federal level. So far, only a handful of states allow the sale of cannabis products.

Over the past couple of years, the sector has rallied on hints that the move is on the way, but the reality is that it could still be quite a while. However, assuming cannabis will eventually be legalized in the U.S. at the federal level, Canopy Growth is positioned well to capitalize. The company, through strategic acquisitions, has established the scale and reach to quickly take advantage of the opening of the American market.

At home, cannabis-infused drinks have not taken off as expected in Canada. That could change in 2022 and 2023 as the end of pandemic restrictions brings the return of festivals, where Canopy Growth and its peers can showcase the products.

Challenges

The black market continues to be a formidable competitor in Canada for legal cannabis products. Canopy Growth has also had to change its product offerings to accommodate shifts in consumer preferences. In what is essentially a commodity market, making money could prove to be difficult in the next few years.

Should you buy Canopy Growth stock now?

The trend isn’t an investor’s friend today and many people have been burned trying to catch this falling knife. Investors might be able to pick up a quick gain on a rebound, but I would keep any speculative bets small at this point.

The turnaround process is going to take time and the next quarterly results might not show much of an improvement.

Canopy Growth’s major shareholder, Constellation Brands, appears committed to seeing the business succeed. That’s positive for shareholders and the financial support from the drinks giant should ensure Canopy Growth survives. The risk for investors, however, is that Constellation Brands might decide to take Canopy Growth private. Depending on the price it pays, investors hoping for a rebound to recoup losses might get burned.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool recommends Constellation Brands. Fool contributor Andrew Walker has no position in any stock mentioned.

More on Cannabis Stocks

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Should You Stay Away From HEXO Stock?

HEXO (TSX:HEXO)(NASDAQ:HEXO) stock is on a downward spiral, and there is little hope it is going to recover soon.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why Did Aurora Cannabis (TSX:ACB) Stock Plunge 75% in 2022?

A prominent cannabis stock has plunged by 75% in 2022, as the company’s losses continue to mount in the face…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Fire & Flower: A Small Pot Stock Poised for Strong Growth

Fire & Flower is a cannabis retailer well-positioned for growth thanks to its digital and delivery initiatives.

Read more »

edit Jars of marijuana
Cannabis Stocks

Why Aurora Cannabis (TSX:ACB) Stock Is Sinking This Week

Starting another round of capital raising has hurt investor sentiments, and the Canadian cannabis giant’s performance on the stock market…

Read more »

edit Jars of marijuana
Cannabis Stocks

Why Canopy Growth (TSX:WEED) Stock Plunged 19% Last Week

Canopy Growth Corp. (TSX:WEED)(NASDAQ:CGC) stock has plunged after the release of its final fiscal 2022 results.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

Why Aurora Cannabis (TSX:ACB) Stock Tanked 45% Last Week

There's no respite for Aurora Cannabis investors!

Read more »

Money growing in soil , Business success concept.
Cannabis Stocks

TFSA Investors: This Undervalued Gem Could Turn $6,000 Into $25,000

Here's why TFSA investors can hold undervalued growth stocks such as Verano in their portfolios right now.

Read more »

TSX Today
Cannabis Stocks

TSX Today: What to Watch for in Stocks on Monday, May 30

TSX investors should keep a close eye on the latest manufacturing data from China today.

Read more »